The levels of testosterone (T), P, FSH and gonadotropin-releasing hormone (GnRH) showed no significant differences (Fig. 1E), indicating that TBT-treated rats showed no hyperandrogenism or obvious disruption of the hypothalamic-pituitary-gonadal axis. The gene discussed is BRD2; the disease is hyperandrogenism.